Johnson and Johnson 2009 Annual Report Download - page 71

CORPORATE AND SHAREHOLDER INFORMATION

One Johnson & Johnson Plaza
New Brunswick, New Jersey 
() 

The Annual Meeting of Shareholders will take
place April , at the Hyatt Regency
New Brunswick,  Albany Street, New Brunswick,
New Jersey. The meeting will convene at  a.m.
All shareholders are cordially invited to attend.
A formal Notice of Meeting, Proxy Statement
and Proxy have been sent to shareholders.

Copies of the Company’s  Annual Report
on Form -K, Quarterly Reports on Form -Q
and Current Reports on Form -K to
the Securities and Exchange Commission,
Proxy Statement, and this Annual Report
are available online at www.investor.jnj.com/
sec-filings.cfm, or to shareholders without
charge upon written request to the Secretary at
the Company’s principal address or by calling
.
In addition, on the Company’s
Corporate Governance web site at
www.investor.jnj.com/governance.cfm,
shareholders can view the Company’s
Principles of Corporate Governance,
Charters of the Audit Committee,
Compensation & Benefits Committee
and Nominating & Corporate Governance
Committee, Policy on Business Conduct
for Employees and Code of Business
Conduct & Ethics for Members of the Board
of Directors and Executive Ocers.
Copies of these documents are available
to shareholders without charge upon written
request to the Secretary at the Company’s
principal address.
The Company is required to file as an Exhibit
to its Form -K for each fiscal year certifica-
tions under Section  of the Sarbanes-Oxley
Act signed by the Chief Executive Ocer
and the Chief Financial Ocer. In addition,
the Company is required to submit a certifica-
tion signed by the Chief Executive Ocer
to the New York Stock Exchange within  days
following the Annual Meeting of Shareholders.
Copies of the certifications filed for previous
years are posted on the Company’s Corporate
Governance web site, and future certifications
will be posted promptly upon filing.

Listed on New York Stock Exchange
Stock Symbol JNJ

Steven M. Rosenberg
Corporate Secretary


Louise Mehrotra
Vice President, Investor Relations



Questions regarding stock holdings,
certificate replacement/transfer, dividends
and address changes should be directed to:
Computershare Trust Company, N.A.
 Royall Street
Canton, MA 
 or
 (outside the U.S.)
www.computershare.com

The Plan allows for full or partial
dividend reinvestment, and additional monthly
cash investments up to $ per year,
in Johnson & Johnson common stock without
brokerage commissions or service charges
on stock purchases. If you are interested in
participating in the Plan and need an authoriza-
tion form and/or more information, please call
Computershare Trust Company, N.A.
at  or 
(outside the U.S.).

Shareholders who have inquiries regarding
stock-related matters can communicate directly
with Computershare Trust Company, N.A.
via a telecommunications device (TDD).
The telephone number for this service is
 or 
(outside the U.S.).
Registered shareholders who wish to receive
electronic notice of online access to future
annual reports and proxy materials instead
of paper copies may register online:
www.computershare-na.com/green
Beneficial Johnson & Johnson shareholders
(you own shares through a broker or bank) can
register for online delivery of
materials by going to:
http://enroll.icsdelivery.com/jnj

Company website: www.jnj.com
Online annual report:
www.investor.jnj.com/ annualreport
Company blog: www.jnjbtw.com
Johnson & Johnson history blog:
www.kilmerhouse.com
Facebook: Follow the Johnson & Johnson
Network
Twitter: @JNJComm
YouTube: www.youtube.com/JNJhealth
©Johnson & Johnson 
The paper used in this publication is made from
% and % post-consumer recycled fiber, is
Forest Stewardship Council certified for chain of custody
and was manufactured with green energy credits for purchase
of electricity generated from renewable-energy sources
such as wind and low-impact hydro resources.

















® is co-developed with Grünenthal GmbH.
Centocor Ortho Biotech, Inc. has marketing rights for ® in the U.S., while Xian-Janssen Pharmaceutical, Ltd. markets the product in China and Janssen-Cilag in Hong Kong.
Distribution agreements are in place with Merck & Co., Inc. and Mitsubishi Tanabe Pharma Corporation in other markets throughout the world.